HIGHLIGHTS
- who: Top from the Department of Cellular Biotechnologies and Haematology, "Sapienza" University of Rome, Italy have published the Article: PARP inhibitor ABT-888 affects response of MDA-MB-231 cells, in the Journal: (JOURNAL)
- what: The authors show that the inhibitor ABT-888 was capable to modulate the MDAMB-231 cell response to doxorubicin leading to an increase in the rate of apoptosis. The authors aimed to evaluate the apoptotic response of MDA-MB-231 cells and its dependence on PARP inhibition. The authors focused the attention on different targets from p53, since in MDA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.